Effectiveness of oral phloroglucinol as a premedication for unsedated esophagogastroduodenoscopy: A prospective, double-blinded, placebo-controlled, randomized trial.

<h4>Background</h4>Anti-spasmodic agents are commonly injected during esophagogastroduodenoscopy (EGD) to improve visualization of the gastric mucosa by inhibiting gastrointestinal (GI) peristalsis. The availability of oral anti-spasmodic agents would increase convenience. In this study,...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: HyeIn Jung, Hyun Jung Kim, Eun Sung Choi, Ju Yup Lee, Kyung Sik Park, Kwang Bum Cho, Yoo Jin Lee
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/3730ec0130bf470abc06d83b6f946e36
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:3730ec0130bf470abc06d83b6f946e36
record_format dspace
spelling oai:doaj.org-article:3730ec0130bf470abc06d83b6f946e362021-12-02T20:18:46ZEffectiveness of oral phloroglucinol as a premedication for unsedated esophagogastroduodenoscopy: A prospective, double-blinded, placebo-controlled, randomized trial.1932-620310.1371/journal.pone.0255016https://doaj.org/article/3730ec0130bf470abc06d83b6f946e362021-01-01T00:00:00Zhttps://doi.org/10.1371/journal.pone.0255016https://doaj.org/toc/1932-6203<h4>Background</h4>Anti-spasmodic agents are commonly injected during esophagogastroduodenoscopy (EGD) to improve visualization of the gastric mucosa by inhibiting gastrointestinal (GI) peristalsis. The availability of oral anti-spasmodic agents would increase convenience. In this study, we evaluated the effectiveness of oral phloroglucinol (Flospan®) as a premedication for unsedated EGD.<h4>Methods</h4>A prospective, double-blinded, placebo-controlled, randomized controlled trial was conducted in a tertiary hospital. Individuals scheduled to undergo unsedated EGD were randomly assigned to receive either oral phloroglucinol or matching placebo 15 min before EGD. The primary outcome was the rate of complete gastric peristalsis suppression. Outcomes were assessed by independent investigators according to the classification of gastric peristalsis and ease of intragastric observation at the beginning (Period A) and end (Period B) of EGD.<h4>Results</h4>Overall, 71 phloroglucinol-treated and 71 placebo-treated participants (n = 142 total) were included. The phloroglucinol group showed significantly higher proportions of participants with complete gastric peristalsis suppression than the placebo group (22.5% vs. 9.9%, P = 0.040). The ease of intragastric observation was significantly better in the phloroglucinol group than in the placebo group at Periods A (P < 0.001) and B (P = 0.005). Patients in both groups had comparable adverse events and showed willingness to take the premedication at their next examination.<h4>Conclusions</h4>Oral phloroglucinol significantly suppressed gastrointestinal peristalsis during unsedated EGD compared with placebo (Clinical trial registration number: NCT03342118).HyeIn JungHyun Jung KimEun Sung ChoiJu Yup LeeKyung Sik ParkKwang Bum ChoYoo Jin LeePublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 16, Iss 8, p e0255016 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
HyeIn Jung
Hyun Jung Kim
Eun Sung Choi
Ju Yup Lee
Kyung Sik Park
Kwang Bum Cho
Yoo Jin Lee
Effectiveness of oral phloroglucinol as a premedication for unsedated esophagogastroduodenoscopy: A prospective, double-blinded, placebo-controlled, randomized trial.
description <h4>Background</h4>Anti-spasmodic agents are commonly injected during esophagogastroduodenoscopy (EGD) to improve visualization of the gastric mucosa by inhibiting gastrointestinal (GI) peristalsis. The availability of oral anti-spasmodic agents would increase convenience. In this study, we evaluated the effectiveness of oral phloroglucinol (Flospan®) as a premedication for unsedated EGD.<h4>Methods</h4>A prospective, double-blinded, placebo-controlled, randomized controlled trial was conducted in a tertiary hospital. Individuals scheduled to undergo unsedated EGD were randomly assigned to receive either oral phloroglucinol or matching placebo 15 min before EGD. The primary outcome was the rate of complete gastric peristalsis suppression. Outcomes were assessed by independent investigators according to the classification of gastric peristalsis and ease of intragastric observation at the beginning (Period A) and end (Period B) of EGD.<h4>Results</h4>Overall, 71 phloroglucinol-treated and 71 placebo-treated participants (n = 142 total) were included. The phloroglucinol group showed significantly higher proportions of participants with complete gastric peristalsis suppression than the placebo group (22.5% vs. 9.9%, P = 0.040). The ease of intragastric observation was significantly better in the phloroglucinol group than in the placebo group at Periods A (P < 0.001) and B (P = 0.005). Patients in both groups had comparable adverse events and showed willingness to take the premedication at their next examination.<h4>Conclusions</h4>Oral phloroglucinol significantly suppressed gastrointestinal peristalsis during unsedated EGD compared with placebo (Clinical trial registration number: NCT03342118).
format article
author HyeIn Jung
Hyun Jung Kim
Eun Sung Choi
Ju Yup Lee
Kyung Sik Park
Kwang Bum Cho
Yoo Jin Lee
author_facet HyeIn Jung
Hyun Jung Kim
Eun Sung Choi
Ju Yup Lee
Kyung Sik Park
Kwang Bum Cho
Yoo Jin Lee
author_sort HyeIn Jung
title Effectiveness of oral phloroglucinol as a premedication for unsedated esophagogastroduodenoscopy: A prospective, double-blinded, placebo-controlled, randomized trial.
title_short Effectiveness of oral phloroglucinol as a premedication for unsedated esophagogastroduodenoscopy: A prospective, double-blinded, placebo-controlled, randomized trial.
title_full Effectiveness of oral phloroglucinol as a premedication for unsedated esophagogastroduodenoscopy: A prospective, double-blinded, placebo-controlled, randomized trial.
title_fullStr Effectiveness of oral phloroglucinol as a premedication for unsedated esophagogastroduodenoscopy: A prospective, double-blinded, placebo-controlled, randomized trial.
title_full_unstemmed Effectiveness of oral phloroglucinol as a premedication for unsedated esophagogastroduodenoscopy: A prospective, double-blinded, placebo-controlled, randomized trial.
title_sort effectiveness of oral phloroglucinol as a premedication for unsedated esophagogastroduodenoscopy: a prospective, double-blinded, placebo-controlled, randomized trial.
publisher Public Library of Science (PLoS)
publishDate 2021
url https://doaj.org/article/3730ec0130bf470abc06d83b6f946e36
work_keys_str_mv AT hyeinjung effectivenessoforalphloroglucinolasapremedicationforunsedatedesophagogastroduodenoscopyaprospectivedoubleblindedplacebocontrolledrandomizedtrial
AT hyunjungkim effectivenessoforalphloroglucinolasapremedicationforunsedatedesophagogastroduodenoscopyaprospectivedoubleblindedplacebocontrolledrandomizedtrial
AT eunsungchoi effectivenessoforalphloroglucinolasapremedicationforunsedatedesophagogastroduodenoscopyaprospectivedoubleblindedplacebocontrolledrandomizedtrial
AT juyuplee effectivenessoforalphloroglucinolasapremedicationforunsedatedesophagogastroduodenoscopyaprospectivedoubleblindedplacebocontrolledrandomizedtrial
AT kyungsikpark effectivenessoforalphloroglucinolasapremedicationforunsedatedesophagogastroduodenoscopyaprospectivedoubleblindedplacebocontrolledrandomizedtrial
AT kwangbumcho effectivenessoforalphloroglucinolasapremedicationforunsedatedesophagogastroduodenoscopyaprospectivedoubleblindedplacebocontrolledrandomizedtrial
AT yoojinlee effectivenessoforalphloroglucinolasapremedicationforunsedatedesophagogastroduodenoscopyaprospectivedoubleblindedplacebocontrolledrandomizedtrial
_version_ 1718374217078013952